Profile

James B. Caress, M.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

113 Ratings
2 Comments

James B. Caress, M.D.

Professor,

Clinical Specialties

Myasthenia Gravis, ALS, Muscle Diseases, Muscle Cramps

Contact Information

Request An Appointment

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-4101
Department: 336-716-7668

Insurance Accepted »

Education & Training

  • B.A., Colgate University , 1986
  • M.D., George Washington University School of Medicine , 1990
  • Internship, Internal Medicine, George Washington U Hosp, 1991
  • Residency, Neurology, Duke University Medical Center, 1994
  • Fellowship, Brigham & Women's Hosp, 1996

Board Certifications

  • American Board of Psychiatry & Neurology, Neurology, Psychiatry & Neurology - Clinical Neurophysiology
  • American Board of Psychiatry & Neurology, Neurology, Psychiatry & Neurology - Neurology
  • American Board of Psychiatry & Neurology, Psychiatry & Neurology - Psychiatry

Memberships

  • American Academy of Neurology

NPI Number

  • 1184600264
James B. Caress, M.D.

Doctor Rating

4.7 out of 5

113 Ratings
2 Comments

James B. Caress, M.D.

Professor, Neurology

Research Interests

drugs/therapeutic agents pharm, health services, research/outc, neurosciences/behavior

Contact Information

Request An Appointment

Academic: 336-716-2309 | Department: 336-716-7668

Recent Publications

Rutkove SB, Caress JB, Cartwright MS, Burns TM, Warder J, David WS, Goyal N, Maragakis NJ, Benatar M, Sharma KR, Narayanaswami P, Raynor EM, Watson ML, Shefner JM. Electrical impedance myography correlates with standard measures of ALS severity. Muscle Nerve. 2014;49(3):441-443.

Meininger V, Pradat PF, Corse A, Al-Sarraj S, Rix Brooks B, Caress JB, Cudkowicz M, Kolb SJ, Lange D, Leigh PN, Meyer T, Milleri S, Morrison KE, Orrell RW, Peters G, Rothstein JD, Shefner J, Lavrov A, Williams N, Overend P, Price J, Bates S, Bullman J,. Safety, pharmacokinetic, and functional effects of the nogo-a monoclonal antibody in amyotrophic lateral sclerosis: a randomized, first-in-human clinical trial. PLoS One. 2014;9(5):e97803.

Berry JD, Shefner JM, Conwit R, Schoenfeld D, Keroack M, Felsenstein D, Krivickas L, David WS, Vriesendorp F, Pestronk A, Caress JB, Katz J, Simpson E, Rosenfeld J, Pascuzzi R, Glass J, Rezania K, Rothstein JD, Greenblatt DJ, Cudkowicz ME. Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis. PLoS One. 2013;8(4):e61177.

Vinsant S, Mansfield C, Jimenez-Moreno R, Moore VDG, Yoshikawa M, Hampton TG, Prevette D, Caress J, Oppenheim RW, Milligan C. Characterization of early pathogenesis in the SOD1G93A mouse model of ALS: part I, background and methods. Brain Behav. 2013;3(4):335-350.

Vinsant S, Mansfield C, Jimenez-Moreno R, Moore VDG, Yoshikawa M, Hampton TG, Prevette D, Caress J, Oppenheim RW, Milligan C. Characterization of early pathogenesis in the SOD1G93A mouse model of ALS: part II, results and discussion. Brain Behav. 2013;3(4):431-457.

Rutkove S, Caress J, Cartwright M, Burns T, Warder J, David W, Goyal N, Maragakis N, Clawson L, Benatar M, Usher S, Sharma K, Guatam S, Narayanaswarmi P, Raynot E, Watson ML, Shefner J. Electrical impedance myography as a biomarker to assess ALS progression [abstract]. Neurology. 2012;78(Suppl 1):S25.006.

Gifondorwa DJ, Jimenz-Moreno R, Hayes CD, Rouhani H, Robinson MB, Strupe JL, Caress J, Milligan C. Administration of recombinant heat shock protein 70 delays peripheral muscle denervation in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Neurol Res Int. 2012;2012():170426.

Rutkove SB, Caress JB, Cartwright MS, Burns TM, Warder J, David WS, Goyal N, Maragakis NJ, Clawson L, Benatar M, Usher S, Sharma KR, Gautam S, Narayanaswami P, Raynor EM, Watson ML, Shefner JM. Electrical impedance myography as a biomarker to assess ALS progression. Amyotroph Lateral Scler. 2012;13(5):439-445.

Shefner JM, Watson ML, Simionescu L, Caress JB, Burns TM, Maragakis NJ, Benatar M, David WS, Sharma KR, Rutkove SB. Multipoint incremental motor unit number estimation as an outcome measure in ALS. Neurology. 2011;77(3):235-241.

Cartwright MS, Walker FO, Griffin LP, Caress JB. Peripheral nerve and muscle ultrasound in amyotrophic lateral sclerosis. Muscle Nerve. 2011;44(3):346-351.


Caress JB, Kennedy BL, Eickman KD. Safety of intravenous immunoglobulin treatment. Expert Opin Drug Saf. 2010;9(6):971-979.

Hernandez S, Texido L, Caldero J, Ciutat D, Piedrafita L, Casanovas A, Caress J, Prevette D, Oppenheim RW, Milligan C, et al. Increased intramuscular nerve branching and inhibition of programmed cell death of chick embryo motoneurons by immunoglobulins from patients with motoneuron disease. J Neuroimmunol. 2010;229(1-2):157-168.

Quaid KA, Swenson MM, Sims SL, Harrison JM, Moskowitz C, Stepanov N, Suter GW, Caress J, Walker F, Hunt V, et al. What were you thinking?: individuals at risk for Huntington Disease talk about having children. J Genet Couns. 2010;19(6):606-617.

Caress JB, Hobson-Webb L, Passmore LV, Finkbiner AP, Cartwright MS. Case-control study of thromboembolic events associated with IV immunoglobulin. J Neurol. 2009;256(3):339-342.

Cartwright MS, Brown ME, Eulitt P, Walker FO, Lawson VH, Caress JB. Diagnostic nerve ultrasound in Charcot-Marie-Tooth disease type 1B. Muscle Nerve. 2009;40(1):98-102.

Yoshikawa M, Vinsant S, Mansfield CM, Gifondorwa DJ, Pace L, Messi LM [sic] [Messi ML], Caress J, Cartwright M, Delbono O, Oppenheim RW, Milligan CE, et al. Identification of changes in muscle, neuromuscular junctions and spinal cord at early pre-symptomatic stages in the mutant SOD1 mouse model of ALS may provide novel insight for diagnosis and treatment development [abstract]. Soc Neurosci Abstr. 2009;2009(Neuroscience Meeting Planner):.

Cartwright MS, Passmore LV, Yoon J-S, Brown ME, Caress JB, Walker FO. Cross-sectional area reference values for nerve ultrasonography. Muscle Nerve. 2008;37(5):566-571.

Shefner JM, Cudkowicz ME, Zhang H, Schoenfeld D, Jillapalli D, Al-Lozi M, Caress JB, David W, Russell J, Graves M, et al. Revised statistical motor unit number estimation in the Celecoxib/ALS trial. Muscle Nerve. 2007;35(2):228-234.

Caress JB, Esper GJ, Rutkove SB. Neurophysiology of nerve conduction studies In: Blum AS, Rutkove SB, eds. The clinical neurophysiology primer. Totowa (NJ): Humana Press;2007: 207-216.

Caress JB. Technical, physiological and anatomic considerations in nerve conduction studies In: Blum AS, Rutkove SB, eds. The clinical neurophysiology primer. Totowa (NJ): Humana Press;2007: 217-227.

Gifondorwa DJ, Robinson MB, Hayes CD, Taylor AR, Prevette DM, Oppenheim RW, Caress J, Milligan CE. Exogenous delivery of heat shock protein 70 increases lifespan in a mouse model of amyotrophic lateral sclerosis. J Neurosci. 2007;27(48):13173-80.

Cudkowicz ME, Shefner JM, Schoenfeld DA, Zhang H, Andreasson KI, Donofrio P, Caress J, Ashburn C, Walker T, Dryman B, et al. Trial of celecoxib in amyotrophic lateral sclerosis. Ann Neurol. 2006;60(1):22-31.

Shoulson I, Kieburtz K, Oakes D, Kayson E, Zhao H, Shinaman A, Romer M, Caress J, Walker F, Hunt V, et al. At risk for Huntington disease: the PHAROS (Prospective Huntington At Risk Observational Study) Cohort enrolled. Arch Neurol. 2006;63(7):991-996.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Neurology

Clinical Specialties

Myasthenia Gravis, ALS, Muscle Diseases, Muscle Cramps
James B. Caress, M.D.

James B. Caress, M.D.

Professor, Neurology

Request An Appointment

Doctor Rating

4.7 out of 5

James B. Caress, M.D.113 Ratings
2 Comments

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.6
CP efforts to include in decisions
4.7
CP explanations of prob/condition
4.7
CP spoke using clear language
4.8
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.7
Patients' confidence in CP
4.7
Time CP spent with patient
4.8
Wait time at clinic
4.4



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

9/3/2014

After not seeing dr. for 1 yr., spent less than 10 min. with me. Did not review medications or status of research.

3/12/2014

Dr. Caress is very good and makes you feel good, when you see him.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.